收藏切换
Recent advancement in targeting the KRAS-G12C mutant for cancer therapy
收藏切换
PDF
Xin LI1, Yi-jun WANG2, Ping-yu LIU*, 2
Acta Pharmaceutica Sinica | 2021, 56(2) : 374 - 382
Less
收藏切换
Acta Pharmaceutica Sinica | 2021, 56(2): 374-382
Reviews
Recent advancement in targeting the KRAS-G12C mutant for cancer therapy
Full
Xin LI1, Yi-jun WANG2, Ping-yu LIU*, 2
Affiliations
  • 1. School of Pharmacy, Nanjing Medical University, Nanjing 211166, China
  • 2. Pharmacy Department, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, China
Published: 2021-02-12 doi: 10.16438/j.0513-4870.2020-1485
Outline
收藏切换

RAS, as a well-known proto-oncogene, is the most frequently mutated oncogene in human cancers, yet tremendous efforts over the past 30 years have failed to develop effective therapies for RAS-mutant cancer.Recently, specifically targeting the KRAS-G12C mutant, a frequently occurring KRAS mutation in human cancers, has shown promise in conquering KRAS-mutant cancers, and has inspired interest in this direction. We herein review the very recent progress achieved in the development of covalent inhibitors towards KRAS-G12C mutant, in combinational therapies and in proteolysis-targeting chimeras(PROTACs)-based approaches to disrupt KRASG12C protein. We provide insights for drug discovery against KRAS-G12C-mutated tumors and discuss the potential challenges in this field.

KRAS mutated cancer  /  KRAS-G12C mutant  /  anticancer drug  /  covalent inhibitor  /  proteolysistargeting chimeras  /  combination therapy
Xin LI, Yi-jun WANG, Ping-yu LIU. Recent advancement in targeting the KRAS-G12C mutant for cancer therapy[J]. Acta Pharmaceutica Sinica, 2021 , 56 (2) : 374 -382 . DOI: 10.16438/j.0513-4870.2020-1485
Year 2021 volume 56 Issue 2
PDF
271
127
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2020-1485
  • Receive Date:2020-09-14
  • Online Date:2025-12-18
  • Published:2021-02-12
Article Data
Affiliations
History
  • Received:2020-09-14
  • Revised:2020-10-28
Funding
Affiliations
    1. School of Pharmacy, Nanjing Medical University, Nanjing 211166, China
    2. Pharmacy Department, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2020-1485
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT